| Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients CA Pierce, P Preston-Hurlburt, Y Dai, CB Aschner, N Cheshenko, B Galen, ... Science translational medicine 12 (564), eabd5487, 2020 | 335 | 2020 |
| A naturally occurring antiviral ribonucleotide encoded by the human genome AS Gizzi, TL Grove, JJ Arnold, J Jose, RK Jangra, SJ Garforth, Q Du, ... Nature 558 (7711), 610-614, 2018 | 262 | 2018 |
| Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation WI Tsou, KQN Nguyen, DA Calarese, SJ Garforth, AL Antes, SV Smirnov, ... Journal of Biological Chemistry 289 (37), 25750-25763, 2014 | 217 | 2014 |
| Panoramic view of a superfamily of phosphatases through substrate profiling H Huang, C Pandya, C Liu, NF Al-Obaidi, M Wang, L Zheng, ... Proceedings of the National Academy of Sciences 112 (16), E1974-E1983, 2015 | 146 | 2015 |
| Anti–CTLA-4 therapy requires an Fc domain for efficacy JR Ingram, OS Blomberg, M Rashidian, L Ali, S Garforth, E Fedorov, ... Proceedings of the National Academy of Sciences 115 (15), 3912-3917, 2018 | 140 | 2018 |
| The Two-Component Regulatory System senX3-regX3 Regulates Phosphate-Dependent Gene Expression in Mycobacterium smegmatis RT Glover, J Kriakov, SJ Garforth, AD Baughn, WR Jacobs Jr Journal of bacteriology 189 (15), 5495-5503, 2007 | 124 | 2007 |
| PD-L1 is an activation-independent marker of brown adipocytes JR Ingram, M Dougan, M Rashidian, M Knoll, EJ Keliher, S Garrett, ... Nature communications 8 (1), 647, 2017 | 110 | 2017 |
| Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity KQN Nguyen, WI Tsou, DA Calarese, SG Kimani, S Singh, S Hsieh, Y Liu, ... Journal of Biological Chemistry 289 (37), 25737-25749, 2014 | 94 | 2014 |
| An Anaerobic-Type α-Ketoglutarate Ferredoxin Oxidoreductase Completes the Oxidative Tricarboxylic Acid Cycle of Mycobacterium tuberculosis AD Baughn, SJ Garforth, C Vilcheze, WR Jacobs Jr PLoS pathogens 5 (11), e1000662, 2009 | 93 | 2009 |
| Characterization of the SARS-CoV-2 S protein: biophysical, biochemical, structural, and antigenic analysis NG Herrera, NC Morano, A Celikgil, GI Georgiev, RJ Malonis, JH Lee, ... ACS omega 6 (1), 85-102, 2020 | 84 | 2020 |
| Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC H ah Yoon, R Bartash, I Gendlina, J Rivera, A Nakouzi, RH Bortz III, ... JCI insight 6 (4), 2021 | 49 | 2021 |
| A herpes simplex virus (HSV)-2 single-cycle candidate vaccine deleted in glycoprotein D protects male mice from lethal skin challenge with clinical isolates of HSV-1 and HSV-2 C Burn, N Ramsey, SJ Garforth, S Almo, WR Jacobs Jr, BC Herold The Journal of infectious diseases 217 (5), 754-758, 2018 | 49 | 2018 |
| Protein production from the structural genomics perspective: achievements and future needs SC Almo, SJ Garforth, BS Hillerich, JD Love, RD Seidel, SK Burley Current opinion in structural biology 23 (3), 335-344, 2013 | 43 | 2013 |
| Mutagenesis of conserved lysine residues in bacteriophage T5 5′-3′ exonuclease suggests separate mechanisms of endoand exonucleolytic cleavage SJ Garforth, TA Ceska, D Suck, JR Sayers Proceedings of the National Academy of Sciences 96 (1), 38-43, 1999 | 42 | 1999 |
| In vivo detection of antigen-specific CD8+ T cells by immuno-positron emission tomography AW Woodham, SH Zeigler, EL Zeyang, SC Kolifrath, RW Cheloha, ... Nature methods 17 (10), 1025-1032, 2020 | 36 | 2020 |
| Structural basis of CD160: HVEM recognition W Liu, SC Garrett, EV Fedorov, UA Ramagopal, SJ Garforth, JB Bonanno, ... Structure 27 (8), 1286-1295. e4, 2019 | 35 | 2019 |
| Structure-specific DNA binding by bacteriophage T5 5′→ 3′ exonuclease SJ Garforth, JR Sayers Nucleic acids research 25 (19), 3801-3807, 1997 | 34 | 1997 |
| A single cleavage assay for T5 5′→ 3′ exonuclease: determination of the catalytic parameters for wild-type and mutant proteins TJ Pickering, SJ Thorpe, JA Grasby, SJ Garforth, JR Sayers Nucleic acids research 27 (3), 730-735, 1999 | 33 | 1999 |
| Syntac polypeptides and uses thereof RD Seidel III, RJ Chaparro, BS Hillerich, SJ Garforth, SC Almo US Patent App. 15/306,678, 2017 | 30 | 2017 |
| The lysine 65 residue in HIV-1 reverse transcriptase function and in nucleoside analog drug resistance SJ Garforth, C Lwatula, VR Prasad Viruses 6 (10), 4080-4094, 2014 | 27 | 2014 |
